Stockscreener 앱 받기
12.82
1.27%
-0.1746
전일 마감가:
$12.99
열려 있는:
$12.95
하루 거래량:
1.00M
Relative Volume:
0.55
시가총액:
$2.22B
수익:
$363.55M
순이익/손실:
$-78.68M
주가수익비율:
-25.63
EPS:
-0.5
순현금흐름:
$50.74M
1주 성능:
-6.59%
1개월 성능:
+34.29%
6개월 성능:
+24.39%
1년 성능:
-27.13%
1일 변동 폭
$12.67
$13.06
1주일 범위
$12.67
$14.04
52주 변동 폭
$8.635
$17.81
Certara Inc Stock (CERT) Company Profile
명칭
Certara Inc
전화
(415) 237-8272
주소
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
CERT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
12.82 | 2.22B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
238.21 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.27 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.67 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
92.38 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.17 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 업그레이드 | UBS | Neutral → Buy |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2023-04-03 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | 개시 | Berenberg | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-01 | 개시 | Piper Sandler | Overweight |
| 2022-01-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-23 | 개시 | Robert W. Baird | Outperform |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-01-05 | 개시 | BofA Securities | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Neutral |
| 2021-01-05 | 개시 | Jefferies | Hold |
| 2021-01-05 | 개시 | William Blair | Outperform |
모두보기
Certara Inc 주식(CERT)의 최신 뉴스
Certara (CERT) to Release Quarterly Earnings on Monday - Defense World
Certara Inc [CERT] Records 50-Day SMA of $11.81 - knoxdaily.com
Certara Inc (CERT) Stock: A Year of Market Fluctuations - investchronicle.com
Perhaps timely catching Certara Inc (CERT) would be a good idea - Sete News
Certara to Participate in Upcoming Investor Conferences | CERT S - GuruFocus
Certara to Participate in Upcoming Investor Conferences - The Manila Times
Global Drug Development Leader Certara Sets Stage at Major Healthcare Conferences This Summer - Stock Titan
Certara Inc (CERT) Shares Gap Down to $13.745 on Apr 28 - GuruFocus
Certara Inc (CERT)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Keeping an Eye on Certara Inc (CERT) After Insider Trading Activity - knoxdaily.com
Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? - MSN
Certara Inc [CERT] Records 200-Day SMA of $12.02 - knoxdaily.com
What is Certara Inc (CERT) Stock Return on Shareholders’ Capital? - Sete News
Market Momentum Report: Certara Inc (CERT)’s Negative Close at 14.25 - DWinneX
Certara, Inc. (NASDAQ:CERT) Shares Sold by Envestnet Asset Management Inc. - Defense World
Investing in Certara Inc (CERT): What You Must Know - knoxdaily.com
3 Momentum Stocks That Could Soar Post-Market Volatility - Investing.com
3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat
Where are the Opportunities in (CERT) - news.stocktradersdaily.com
Geode Capital Management LLC Sells 10,953 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Computer Aided Drug Discovery Market Future Prospects 2030 | Certara, Chemical Computing Group - openPR.com
LPL Financial LLC Increases Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - MSN
Certara, Inc. (NASDAQ:CERT) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Certara (NASDAQ:CERT) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
Certara FY2025 EPS Estimate Increased by Leerink Partnrs - Defense World
Equities Analysts Set Expectations for Certara Q1 Earnings - Defense World
Leerink Partnrs Has Positive Outlook of Certara Q1 Earnings - Defense World
Certara Inc (CERT) Shares Gap Down to $13.69 on Apr 15 - GuruFocus
Certara expects Q1 sales above estimates - MSN
William Blair Analysts Lower Earnings Estimates for Certara - Defense World
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues - simplywall.st
O Shaughnessy Asset Management LLC Has $138,000 Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara (CERT) Exceeds Revenue Expectations with Strong Q1 Growt - GuruFocus
Certara (CERT) Explores Strategic Options for Regulatory Services Unit | CERT Stock News - GuruFocus
Certara (CERT) Reaffirms 2025 Financial Projections | CERT Stock News - GuruFocus
Why Certara Inc. (CERT) Soared Last Week? - MSN
Certara (NASDAQ:CERT) Shares Up 8.8% Following Analyst Upgrade - Defense World
Why Certara Inc. (CERT) Skyrocketed On Monday? - MSN
Certara (CERT) Secures One-Year Lock-Up Agreement with Arsenal C - GuruFocus
Certara's Stock Soars on Strong Revenue Guidance and AI-Driven Innovations - GuruFocus
Certara (CERT) Reports Strong Growth in Q1 2024 Performance | CE - GuruFocus
Certara launches Non-Animal Navigator for drug development By Investing.com - Investing.com South Africa
Certara announces Q1 revenue growth and $100 million buyback By Investing.com - Investing.com South Africa
Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report - Benzinga
Certara Launches Product for Biopharmaceutical Firms to Reduce Reliance on Animal Testing - marketscreener.com
Certara Reports Preliminary First Quarter 2025 Financial Results - marketscreener.com
Certara IncEntered Into Amendment To Previously Disclosed Letter Agreement Between Co And Arsenal Saturn Holdings Lp - marketscreener.com
Certara Launches Non-Animal Navigator™ Solution to Help Drug Dev - GuruFocus
Certara announces Q1 revenue growth and $100 million buyback - Investing.com Australia
Certara Inc (CERT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.28%
0.07%
자본화:
|
볼륨(24시간):